Merck & Co., Inc. Proceeds from Debt 2007-2025 | MRK
Beta
What is Merck & Co., Inc.'s current proceeds from debt?
Merck & Co., Inc. (MRK) annual proceeds from debt for 2025 was $13.88B, a 285.66% increase from 2024. Merck & Co., Inc. proceeds from debt for the quarter ending September 30, 2025 was $5.96B.
What was Merck & Co., Inc.'s proceeds from debt in 2024?
Merck & Co., Inc. annual proceeds from debt for 2024 was $3.60B, a 39.40% decline from 2023.
What was Merck & Co., Inc.'s proceeds from debt in 2023?
Merck & Co., Inc. annual proceeds from debt for 2023 was $5.94B, a Infinity% increase from 2022.
What is Merck & Co., Inc.'s 5-year proceeds from debt CAGR?
Merck & Co., Inc. proceeds from debt grew at a compound annual growth rate (CAGR) of 25.72% from FY2020 to FY2025, going from $4.42B to $13.88B over 5 years.
Proceeds from Debt History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR+25.7%
FY2020
$4.42B
→
FY2025
$13.88B
07080910111213141516171819202122232425
5 years selected
Proceeds from Debt History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $13.88B | +285.7% | 10-K |
| FY2024 | $3.60B | -39.4% | 10-K |
| FY2023 | $5.94B | - | 10-K |
| FY2022 | $0 | -100.0% | 10-K |
| FY2021 | $7.94B | +79.6% | 10-K |
| FY2020 | $4.42B | -10.9% | 10-K |
| FY2019 | $4.96B | - | 10-K |
| FY2018 | $0 | - | 10-K |
| FY2017 | $0 | -100.0% | 10-K |
| FY2016 | $1.08B | -86.4% | 10-K |
| FY2015 | $7.94B | +152.3% | 10-K |
| FY2014 | $3.15B | -51.4% | 10-K |
| FY2013 | $6.47B | +152.4% | 10-K |
| FY2012 | $2.56B | - | 10-K |
| FY2011 | $0 | -100.0% | 10-K |
| FY2010 | $2.00B | -52.7% | 10-K |
| FY2009 | $4.23B | - | 10-K |
| FY2008 | $0 | - | 10-K |
| FY2007 | $0 | - | 10-K |
Company: Merck & Co., Inc.Ticker: MRKSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →